PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
296.00
+14.00 (4.96%)
Nov 5, 2026, 3:40 PM WIB
IDX:DGNS Revenue
PT Diagnos Laboratorium Utama Tbk had revenue of 45.66B IDR in the quarter ending September 30, 2026, with 10.31% growth. This brings the company's total for the last twelve months to 180.75B, up 14.41% year-over-year. In the year 2025, PT Diagnos Laboratorium Utama Tbk had annual revenue of 166.62B with 2.18% growth. That makes PT Diagnos Laboratorium Utama Tbk the 37,390th largest company in the world by revenue and 673rd in Indonesia.
Revenue (ttm)
180.75B
Revenue Growth
+14.41%
P/S Ratio
2.22
Revenue / Employee
2.08B
Employees
87
Market Cap
407.00B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 166.62B | 3.55B | 2.18% |
| Dec 31, 2024 | 163.07B | 17.38B | 11.93% |
| Dec 31, 2023 | 145.70B | -47.19B | -24.47% |
| Dec 31, 2022 | 192.89B | -109.30B | -36.17% |
| Dec 31, 2021 | 302.18B | 119.01B | 64.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 38.31T |
| PT Siloam International Hospitals Tbk | 13.91T |
| PT Mitra Keluarga Karyasehat Tbk | 5.66T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.72T |
| PT Itama Ranoraya Tbk | 1.04T |
| PT Royal Prima Tbk | 326.63B |
| PT Diastika Biotekindo Tbk | 224.95B |
| PT UBC Medical Indonesia Tbk | 214.40B |